COVID status | |||
---|---|---|---|
Drug | Non-COVID (n = 188) | COVID (n = 203) | p |
Fentanyl | Â | Â | Â |
 n (%) | 148 (78.7) | 184 (90.6) |  < 0.01 |
 Cumulative dose (mcg) | 1562 (509–4063) | 5350 (3275–8050) |  < 0.01 |
Propofol | Â | Â | Â |
 n (%) | 143 (76.1) | 164 (80.8) | 0.26 |
 Cumulative dose (mg) | 2324 (1021–6443) | 4047 (1227–8127) | 0.02 |
Midazolam | Â | Â | Â |
 n (%) | 36 (19.1) | 114 (56.2) |  < 0.01 |
 Cumulative dose (mg) | 4.0 (2.0–30.0) | 31.5 (5.0–155.0) |  < 0.01 |
Dexmedetomidine | Â | Â | Â |
 n (%) | 91 (48.4) | 52 (25.6) |  < 0.01 |
 Cumulative dose (mcg/kg) | 5.3 (2.2–15.4) | 5.3 (1.6–13.1) | 0.67 |
Lorazepam | Â | Â | Â |
 n (%) | 17 (9.0) | 21 (10.3) | 0.66 |
 Cumulative dose (mg) | 2.0 (1.5–11.0) | 2.0 (1.0–3.5) | 0.37 |
Hydromorphone | Â | Â | Â |
 n (%) | 38 (20.2) | 23 (11.3) | 0.02 |
 Cumulative dose (mg) | 4.5 (2.0–11.0) | 71.0 (9.0–108.0) |  < 0.01 |
Oxycodone | Â | Â | Â |
 n (%) | 28 (14.9) | 18 (8.9) | 0.07 |
 Cumulative dose (mg) | 17.5 (10.0–37.5) | 20.0 (10.0–35.0) | 0.76 |
Morphine | Â | Â | Â |
 n (%) | 1 (0.5) | 7 (3.4) | 0.04 |
 Cumulative dose (mg) | 8.0 (NA) | 3.5 (2.0–12.8) | 0.86 |
Ketamine | Â | Â | Â |
 n (%) | 16 (8.5) | 32 (15.8) | 0.03 |
 Cumulative dose (mg) | 92.5 (50.0–350.0) | 950.0 (234.0–2050.0) |  < 0.01 |
Haloperidol | Â | Â | Â |
 n (%) | 14 (7.4) | 8 (3.9) | 0.13 |
 Cumulative dose (mg) | 5.0 (5.0–11.3) | 5.0 (5.0–8.8) | 0.37 |
Quetiapine | Â | Â | Â |
 n (%) | 5 (2.7) | 11 (5.4) | 0.17 |
 Cumulative dose (mg) | 50.0 (37.5–300.0) | 200.0 (25.0–250.0) | 0.91 |
Gabapentin | Â | Â | Â |
 n (%) | 13 (6.9) | 9 (4.4) | 0.29 |
 Cumulative dose (mg) | 600.0 (300.0–2100.0) | 800.0 (350.0–2100.0) | 0.85 |
Neuromuscular blocker | Â | Â | Â |
 n (%) | 4 (2.1) | 84 (41.4) |  < 0.01 |
RASS level ICU day 1 |  − 2 (− 3 to − 1) |  − 3 (− 4 to − 2) |  < 0.01 |
SAS level ICU day 1 | 3 (3–4) | 2 (1–4) |  < 0.01 |
RASS level ICU day 2 |  − 1 (− 2 to 0) |  − 3 (− 5 to − 2) |  < 0.01 |
SAS level ICU day 2 | 4 (3–4) | 3 (1–3) |  < 0.01 |
RASS level ICU days 3–7 | 0 (− 2 to 0) |  − 3 (− 5 to − 2) |  < 0.01 |
SAS level ICU days 3–7 | 4 (3–4) | 2 (1–3) |  < 0.01 |
Deep sedation ICU day 1, n (%) | 73 (38.8) | 118 (58.1) |  < 0.01 |
Deep sedation ICU day 2, n (%)* | 43 (25.9) | 117 (60.6) |  < 0.01 |
Deep sedation ICU days 3–7, n (%)** | 25 (19.4) | 109 (61.6) |  < 0.01 |
Deep sedation until death, n (%) | 16 (8.5) | 78 (38.4) |  < 0.01 |